QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-dbv-technologies-maintains-5-price-target

HC Wainwright & Co. analyst Andrew Fein reiterates DBV Technologies (NASDAQ:DBVT) with a Buy and maintains $5 price target.

 jmp-securities-maintains-market-outperform-on-dbv-technologies-raises-price-target-to-5

JMP Securities analyst Jonathan Wolleben maintains DBV Technologies (NASDAQ:DBVT) with a Market Outperform and raises the pr...

 dbv-technologies-faces-uncertainties-in-securing-necessary-financing-under-favorable-terms-due-to-potential-global-financial-disruptions-with-risks-exacerbated-by-economic-downturns-potentially-forcing-operational-scale-backs-or-unwanted-collaborative-financial-arrangements-without-adjustments-made-in-this-financial-statement-for-going-concern-uncertainties

The Company intends to seek additional capital as it continues research and development efforts and prepares for the launch of ...

 dbv-technologies-q2-eps-034-beats-045-estimate-sales-116m-miss-168m-estimate

DBV Technologies (NASDAQ:DBVT) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0....

 dbv-technologies-announces-plan-to-implement-ads-ratio-change-from-1-ads-to-12-of-a-ordinary-share-to-1-ads-to-1-ordinary-share-anticipates-that-the-ads-ratio-change-will-be-effective-on-or-about-june-7th-2024

DBV Technologies, a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunolo...

 dbv-technologies-announces-plan-to-implement-ads-ratio-change-from-the-current-ads-ratio-of-1-ads-to-12-of-one-1-ordinary-share-to-a-new-ads-ratio-of-one-1-ads-to-1-ordinary-share

DBV Technologies Announces Plan to Implement ADS Ratio ChangeDBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stoc...

 hc-wainwright--co-maintains-buy-on-dbv-technologies-lowers-price-target-to-5

HC Wainwright & Co. analyst Andrew Fein maintains DBV Technologies (NASDAQ:DBVT) with a Buy and lowers the price target ...

 dbv-technologies-q1-eps-028-beats-021-estimate-sales-140m-miss-227m-estimate

DBV Technologies (NASDAQ:DBVT) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $(0....

 dbv-technologies-q4-2023-gaap-eps-0060-sales-8875m-beat-412000k-estimate

DBV Technologies (NASDAQ:DBVT) reported quarterly losses of $(0.060) per share. The company reported quarterly sales of $8.875...

 earnings-scheduled-for-march-7-2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

 hc-wainwright--co-reiterates-buy-on-dbv-technologies-maintains-10-price-target

HC Wainwright & Co. analyst Andrew Fein reiterates DBV Technologies (NASDAQ:DBVT) with a Buy and maintains $10 price tar...

 dbv-technologies-and-2-other-stocks-under-2-insiders-are-buying

The Dow Jones index closed higher by around 50 points on Thursday. When insiders purchase or sell shares, it indicates their co...

 top-5-health-care-stocks-that-could-blast-off-in-december

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION